172 related articles for article (PubMed ID: 12692073)
1. Which 5-ASA?
Mansfield JC
Gut; 2003 May; 52(5):771. PubMed ID: 12692073
[No Abstract] [Full Text] [Related]
2. [5-ASA versus sulfasalazine].
Varela E
Acta Gastroenterol Latinoam; 1994; 25(5):317-9. PubMed ID: 7785405
[No Abstract] [Full Text] [Related]
3. [Pharmacological bases of therapy with 5-ASA].
Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
[No Abstract] [Full Text] [Related]
4. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
[TBL] [Abstract][Full Text] [Related]
5. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T
Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of treatment for ulcerative colitis.
Steinberg H
JAMA; 1998 Aug; 280(5):422. PubMed ID: 9701075
[No Abstract] [Full Text] [Related]
7. Which 5-ASA?
Travis SP
Gut; 2002 Oct; 51(4):548-9. PubMed ID: 12235078
[No Abstract] [Full Text] [Related]
8. The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria.
Edmond LM; Hopkins MJ; Magee EA; Cummings JH
Inflamm Bowel Dis; 2003 Jan; 9(1):10-7. PubMed ID: 12656132
[TBL] [Abstract][Full Text] [Related]
9. [Salicylates in the treatment of Crohn disease].
Mangiarotti R; Prantera C
Ann Ital Chir; 1994; 65(3):279-81. PubMed ID: 7887577
[No Abstract] [Full Text] [Related]
10. The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review.
Kane SV; Bjorkman DJ
Rev Gastroenterol Disord; 2003; 3(4):210-8. PubMed ID: 14668693
[TBL] [Abstract][Full Text] [Related]
11. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Sutherland L; Macdonald JK
Cochrane Database Syst Rev; 2006 Apr; (2):CD000544. PubMed ID: 16625537
[TBL] [Abstract][Full Text] [Related]
12. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Sutherland L; Roth D; Beck P; May G; Makiyama K
Cochrane Database Syst Rev; 2002; (4):CD000544. PubMed ID: 12519547
[TBL] [Abstract][Full Text] [Related]
13. [Treatment and recurrence prevention ulcerative colitis].
Schölmerich J
Internist (Berl); 1995 Dec; 36(12):1124-32. PubMed ID: 8567217
[No Abstract] [Full Text] [Related]
14. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
15. Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease.
Brzezinski A; Rankin GB; Seidner DL; Lashner BA
Cleve Clin J Med; 1995; 62(5):317-23. PubMed ID: 7586488
[TBL] [Abstract][Full Text] [Related]
16. 5-ASA enema therapy.
Hanauer SB
Neth J Med; 1989 Jun; 35 Suppl 1():S11-20. PubMed ID: 2702307
[TBL] [Abstract][Full Text] [Related]
17. Will the real 5-aminosalicylic acid please stand up?
Regueiro MD
Inflamm Bowel Dis; 1999 May; 5(2):147-8. PubMed ID: 10338387
[No Abstract] [Full Text] [Related]
18. Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease.
Mahmud N; Weir DG; Kelleher D
Ir J Med Sci; 1999; 168(4):228-32. PubMed ID: 10624358
[TBL] [Abstract][Full Text] [Related]
19. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
Cohen HD; Das KM
J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S150-4. PubMed ID: 16885699
[TBL] [Abstract][Full Text] [Related]
20. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Wang Y; MacDonald JK; Hanauer S
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
